The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Much Is The Pharmaceutical Excipients Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?
The pharmaceutical excipients market has experienced substantial growth in recent years. It is forecast to expand from $10822.05 billion in 2025 to $11529.87 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.5%. This historical expansion is attributable to factors including heightened demand for oral formulations, the burgeoning pharmaceutical manufacturing sector in APAC, the uptake of synthetic excipients, strict regulatory clearances, and an increase in research and development activities in drug formulation.
The pharmaceutical excipients market is projected for robust expansion over the coming years. Its valuation is anticipated to reach $14867 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.6%. This projected increase throughout the forecast period stems from factors such as the rise of personalized medicine, a significant increase in biopharmaceutical output, the growing need for natural and clean-label excipients, innovations in excipient synthesis technology, and the broadening reach of contract manufacturing organizations (CMOs). Key developments expected during this period involve innovative excipient formulations, improved drug stability solutions, advanced targeted drug delivery systems, the adoption of natural and plant-based excipients, and the development of multi-functional excipients.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3415&type=smp
What Drivers Are Influencing The Pharmaceutical Excipients Market?
Anticipated growth in biologics sales is set to drive the expansion of the pharmaceutical sterility testing market in the future. Biological products, commonly known as biologics, are medications originating from living organisms, encompassing diverse items like vaccines, blood and its constituents, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Within biologics, pharmaceutical excipients are employed to improve their stability, refine their formulation, and guarantee the effective administration of active biological agents. For example, reports from the Generics and Biosimilars Initiative, a Belgium-based entity offering high-quality scientific data on generic and biosimilar medicines, indicated in October 2024 that, besides the top nine biologics, two more intricate drugs achieved notable sales figures in 2023. Specifically, Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both used for treating type 2 diabetes, generated sales of US$14 billion and US$7.2 billion, respectively. Consequently, the increase in biologics sales is propelling the pharmaceutical excipients market.
What Major Segment Divisions Exist Within The Pharmaceutical Excipients Market?
The pharmaceutical excipients market covered in this report is segmented –
1) By Product: Inorganic Chemicals, Organic Chemicals, Other Products
2) By Functionality: Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities
3) By Type Of Formulation: Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations
Subsegments:
1) By Inorganic Chemicals: Salts, Oxides, Silicates
2) By Organic Chemicals: Sugars, Polymers, Oils And Fats
3) By Other Products: Natural Excipients, Coatings, Antioxidants
How Are Trends Shaping The Direction Of The Pharmaceutical Excipients Market?
Leading companies in the pharmaceutical excipient market are rolling out advanced excipients, such as high-purity excipients, to boost drug formulation stability, improve bioavailability, and support complex drug delivery systems. High-purity excipients are defined as pharmaceutical excipients that have undergone sophisticated purification processes to remove impurities and contaminants. For instance, in October 2023, Clariant, a Switzerland-based specialty chemical company, introduced three new VitiPure excipients engineered to enhance the stability and solubility of active pharmaceutical ingredients (APIs). These include VitiPure O 80 Superior, a high-purity polysorbate 80; VitiPure CO 35 Superior, a polyoxyl 35 castor oil; and VitiPure Meglumine LEX, a solubilizer with low bioburden. Targeting diverse drug delivery applications, especially for sensitive formulations like mRNA vaccines and biologics, these excipients fulfill the increasing demand for high-purity ingredients while complying with stringent regulatory standards.
Which Companies Are Leading Innovation In The Pharmaceutical Excipients Market?
Major companies operating in the pharmaceutical excipients market are BASF SE, Ashland Global Holdings, Evonik Industries AG, International Flavors & Fragrances Inc, Roquette Frères, Archer Daniels Midland Company, Lubrizol Corporation, Croda International Plc, Kerry Group, DuPont de Nemours Inc., Amster Microcell Private Limited, Finar Limited, P. D. Polychem Private Limited, CAD Pharma Inc, Maas Pharma Chemicals, Aeon Procare Private Limited, CSPC Pharmaceutical Group Ltd, Allen & Hanburys Ltd, Colorcon, MEGGLE GmbH & Co. KG, DMV-Fonterra Excipients GmbH & Co. KG, Alpen Pharma AG, Avantor Inc, JRS PHARMA GmbH & Co. KG, The Dow Chemical Co, EMS Pharma, Biolab Farmaceutica, Medist FZE, W.R. Grace, Univar Solutions, Nitika Pharma, DFE Pharma, Cargill, Sensient Pharma
Read the full pharmaceutical excipients market report here:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Which Regions Are Expected To Experience Rapid Expansion In The Pharmaceutical Excipients Market?
North America is the largest region in the pharmaceutical excipients market in 2025. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pharmaceutical Excipients Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3415&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Excipients Market 2026, By The Business Research Company
Pharmaceutical Excipient Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Organic Pharmaceutical Excipients Market Report 2026
Alcohol Excipients Market Report 2026
https://www.thebusinessresearchcompany.com/report/alcohol-excipients-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model